Skip to main content
Log in

Aflatoxin B-oxide generated by chemical or enzymic oxidation of aflatoxin B1 causes guanine substitution in nucleic acids

  • Letter
  • Published:

From Nature

View current issue Submit your manuscript

A Corrigendum to this article was published on 29 September 1977

Abstract

AFLATOXIN B1 (AFB1) has the highest biological activity of the four naturally occurring aflatoxins produced by the mould Aspergillus flavus1. Feeding studies have shown it to be the most potent liver carcinogen known for the rat2. Its ingestion by man is associated with the high primary liver cancer incidence in certain parts of Africa3. There is much evidence to suggest that AFB1 requires metabolism to exert both its carcinogenic and mutagenic effects (reviewed in ref. 4). Structure-activity5, as well as chemical studies6,7 indicate that the major route for activation proceeds through mixed function oxidase attack yielding the 8,9-oxide (previously called the 2,3-oxide but renumbered according to IUPAC recommendations). Attempts to chemically synthesise this metabolite have so far been unsuccessful. We report here that peracid oxidation of AFB1 generates AFB1-8,9-oxide, and that this latter compound reacts readily with nucleic acids to give adducts identical to those obtained after liver mixed function oxidase (MFO) activation in vitro and in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wogan, G. N. in Methods in Cancer Research (ed. Busch, H.) 309–344 (Academic, New York,1973).

    Google Scholar 

  2. Wogan, G. N., Paglialunga, S. & Newberne, P. M., Fd. Cosmet. Toxicol. 12, 681–685 (1974).

    Article  CAS  Google Scholar 

  3. Peers, F. G., Gilman, G. A. & Linsell, C. A., Int. J. Cancer 17, 167–176 (1976).

    Article  CAS  Google Scholar 

  4. Campbell, T. C. & Hayes, J. R., Toxicol. appl. Pharm. 35, 199–222 (1976).

    Article  CAS  Google Scholar 

  5. Garner, R. C., Miller, E. C. & Miller, J. A., Cancer Res. 32, 2058–2066 (1972).

    CAS  PubMed  Google Scholar 

  6. Swenson, D. H., Miller, E. C. & Miller, J. A., Biochem. biophys. Res. Commun. 60, 1036–1043 (1974).

    Article  CAS  Google Scholar 

  7. Garner, R. C., FEBS Lett. 36, 261–264 (1973).

    Article  CAS  Google Scholar 

  8. Anderson, W. K. & Veysoglu, T., J. Org. Chem. 38, 2267–2268 (1973).

    Article  CAS  Google Scholar 

  9. Miller, C. T., Lawley, P. D. & Shah, S. A., Biochem. J. 136, 387–393 (1973).

    Article  CAS  Google Scholar 

  10. Lawley, P. D. & Thatcher, C. A., Biochem. J. 116, 693–707 (1970).

    Article  CAS  Google Scholar 

  11. Lawley, P. D. & Brookes, P., Biochem. J. 89, 127–138 (1963).

    Article  CAS  Google Scholar 

  12. Lawley, P. D. & Shah, S. A., Chem.-Biol. Interact. 7, 115–120 (1973).

    Article  CAS  Google Scholar 

  13. Swenson, D. H., Lin, J. K., Miller, E. C. & Miller, J. A., Cancer Res. 37, 172–181 (1977).

    CAS  PubMed  Google Scholar 

  14. Garner, R. C., Chem.-Biol. Interact. 6, 125–129 (1973).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The erratum article can be found online at https://doi.org/10.1038/269450d0

Rights and permissions

Reprints and permissions

About this article

Cite this article

MARTIN, C., GARNER, R. Aflatoxin B-oxide generated by chemical or enzymic oxidation of aflatoxin B1 causes guanine substitution in nucleic acids. Nature 267, 863–865 (1977). https://doi.org/10.1038/267863a0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/267863a0

  • Springer Nature Limited

This article is cited by

Navigation